Abstract Details
|
Jennifer Lyons, MD
(Brigham and Women's Hospital)
PRESENTER |
Dr. Lyons has received personal compensation for serving as an employee of Biogen. Dr. Lyons has received stock or an ownership interest from Biogen. |
| Reyna Duron, MD (UCLA/VA Medical Center) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Farrah J. Mateen, MD, PhD, FÂ鶹´«Ã½Ó³» (Northwestern University Department of Neurology) | Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care. |